Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(22%)
Results Posted
57%(4 trials)

Phase Distribution

Ph phase_4
1
11%
Ph phase_3
6
67%
Ph phase_1
1
11%
Ph phase_2
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
6(66.7%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(7)

Detailed Status

Completed7
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 36 (66.7%)
Phase 41 (11.1%)

Trials by Status

active_not_recruiting111%
recruiting111%
completed778%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_3

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT06430801
active_not_recruitingphase_3

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT06052059
completedphase_4

Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

NCT05046132
completedphase_3

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)

NCT00500656
completedphase_1

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

NCT01367535
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06430801Phase 3

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT06052059Phase 3

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Active Not Recruiting
NCT05046132Phase 4

Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

Completed
NCT00500656Phase 3

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)

Completed
NCT01367535Phase 1

Effects of MNTX on CYP450 2D6 in Metabolizers of Dextromethorphan

Completed
NCT00401362Phase 3

A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients

Completed
NCT00402038Phase 3

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

Completed
NCT01691521Phase 3

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Completed
NCT01405820Phase 2

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

Completed

All 9 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
9